[177Lu]Lu-PSMA

Lutetium-177 labeled PSMA-targeted radioligand therapy

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for [177Lu]Lu-PSMA, covering 2026-01-06 to 2026-01-06. Get the full timeline:

Most recent: Clinical Trial Update: Study of Re-treatment With [177Lu]Lu-PSMA in Men With Metastatic Castration Resistance Prostate Cancer [Phase 2]